Learn about the immune system and immune checkpoint targets, as well as everything the oncology AP needs to know about managing immune-related adverse events.
Clinical Advances and Case Studies in Immune Checkpoint Inhibitors in Oncology
Immunotherapy has transformed the way oncology advanced practitioners care for patients with cancer. In this activity, get a comprehensive overview of the immune system, including immune checkpoint targets and their mechanisms of action, and learn about how to manage a wide range of immune-related adverse events through case studies centered around patients with non–small cell lung cancer, melanoma, and other malignancies.
This activity is supported by independent educational grants from AstraZeneca and Bristol-Myers Squibb.
These CME/CE/CPE certified activities are jointly provided by